Abstract: The objective of this study was to determine the extent that nebulized glycosylated caffeic acid phenylether ester-4-O-alpha-D-glucopyranoside (G-CAPE) attenuates particulate-induced airway inflammation in healthy horses. Our hypothesis was that nebulization with G-CAPE would result in improved respiratory scores, higher arterial oxygen partial pressure, and less inflammatory airway infiltrates in horses with induced airway inflammation, compared with untreated controls. Five healthy adult horses were housed inside a climate controlled, closed barn on straw bedding and fed moldy grass hay for 16 days to induce airway inflammation. An experimental crossover study was performed in which animals were treated with 200 mg G-CAPE dissolved in 45 mL of 10% triethanolamine (G-CAPE group) or 45 mL of 10% triethanolamine (CONTROL group), and clinical respiratory scoring, arterial blood gases, and bronchoalveolar lavages (BALs) were collected at predetermined time points up to 24 h post nebulization. While the mean neutrophil percentage decreased in treated horses compared to controls (9.3 ± 2.0 and 16.9 ± 2.4, respectively) at 6 hours post treatment ( = 6 h), the difference did not achieve statistical significance ( = 0.1154). Blood gas analysis did not differ significantly between groups. There was a significant difference in the mean respiratory scores of G-CAPE-treated horses between baseline and at 1-h post treatment (from 3.2 ± 0.7 to 1.6 ± 0.7, = 0.0013). This study demonstrates that a single nebulized dose of G-CAPE decreased clinical respiratory scores 1 h post administration and decreased BAL percentage of neutrophils 6 h post administration in horses with particulate induced airway inflammation. This compound shows promise as an anti-inflammatory and warrants further investigation.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The study is about investigating the potential of nebulized glycosylated caffeic acid phenylether ester, also known as G-CAPE, in reducing airway inflammation in horses exposed to moldy hay and straw bedding in a controlled environment.
Study Objective and Hypothesis
The main objective of this research endeavor was to determine the effect of nebulized G-CAPE on particulate-induced inflammation in the airways of healthy horses.
The researchers hypothesized that nebulizing horses with G-CAPE would lead to improved respiratory scores, an increase in arterial oxygen partial pressure, and a decrease in inflammatory airway infiltrates as compared to those left untreated.
Methodology
The study involved five healthy adult horses, which were kept in a controlled environment (a closed barn) and fed moldy grass and straw bedding for 16 days to induce airway inflammation.
Then the scientists performed an experimental crossover study, treating the horses either with G-CAPE dissolved in triethanolamine or with only triethanolamine (control group).
The researchers evaluated the clinical respiratory scores, arterial blood gases, and performed bronchoalveolar lavages (BALs) at predetermined time points up to 24 hours after the treatment.
Findings
The researchers found that the horses treated with G-CAPE showed a reduction in the percentage of neutrophils in BAL samples, six hours after treatment as compared to the control group. However, the difference was not statistically significant.
Blood gas analyses did not reveal significant differences between the two groups. The amount of arterial oxygen pressure in the blood remained relatively similar.
Nonetheless, respiratory scores showed a significant reduction, from a score of 3.2 to 1.6, after one hour of treatment with G-CAPE. This indicated improved respiration in the treated horses.
Conclusion
The article concludes that a single dosage of nebulized G-CAPE decreased clinical respiratory scores in horses with particulate induced airway inflammation 1 hour after administration, and managed to decrease BAL percentage of neutrophils 6 hours post-administration.
This suggests that G-CAPE may have anti-inflammatory effects and further study for its potential as a therapeutic agent in similar inflammatory conditions is merited.
Cite This Article
APA
Rutledge JJ, Paegelow J, Ritchey J, Singh A, Rizzi T, Murray C, Gilliam L, Crisman E, Williams NJ, Holbrook TC.
(2022).
Nebulized glycosylated caffeic acid phenylether ester attenuation of environmental particulate-induced airway inflammation in horses.
Front Vet Sci, 9, 958567.
https://doi.org/10.3389/fvets.2022.958567
Department of Veterinary Clinical Sciences, Oklahoma State University, Stillwater, OK, United States.
Paegelow, Jillian
Department of Veterinary Clinical Sciences, Oklahoma State University, Stillwater, OK, United States.
Ritchey, Jerry
Department of Veterinary Pathobiology, Oklahoma State University, Stillwater, OK, United States.
Singh, Anuradha
Department of Chemistry, Oklahoma State University, Stillwater, OK, United States.
Rizzi, Theresa
Department of Veterinary Pathobiology, Oklahoma State University, Stillwater, OK, United States.
Murray, Cynthia
Department of Mathematics and Statistics, University of Central Oklahoma, Edmond, OK, United States.
Gilliam, Lyndi
Department of Veterinary Clinical Sciences, Oklahoma State University, Stillwater, OK, United States.
Crisman, Evan
Department of Veterinary Clinical Sciences, Oklahoma State University, Stillwater, OK, United States.
Williams, Natasha J
Department of Veterinary Clinical Sciences, Oklahoma State University, Stillwater, OK, United States.
Holbrook, Todd C
Department of Veterinary Clinical Sciences, Oklahoma State University, Stillwater, OK, United States.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Jung WK, Lee DY, Choi YH, Yea SS, Choi I, Park SG, Seo SK, Lee SW, Lee CM, Kim SK, Jeon YJ, Choi IW. Caffeic acid phenethyl ester attenuates allergic airway inflammation and hyperresponsiveness in murine model of ovalbumin-induced asthma.. Life Sci 2008 Mar 26;82(13-14):797-805.
Natarajan K, Singh S, Burke TR Jr, Grunberger D, Aggarwal BB. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B.. Proc Natl Acad Sci U S A 1996 Aug 20;93(17):9090-5.
Ma Y, Zhang JX, Liu YN, Ge A, Gu H, Zha WJ, Zeng XN, Huang M. Caffeic acid phenethyl ester alleviates asthma by regulating the airway microenvironment via the ROS-responsive MAPK/Akt pathway.. Free Radic Biol Med 2016 Dec;101:163-175.
Li Y, Liu LH, Yu XQ, Zhang YX, Yang JW, Hu XQ, Zhang HB. Transglycosylation Improved Caffeic Acid Phenethyl Ester Anti-Inflammatory Activity and Water Solubility by Leuconostoc mesenteroides Dextransucrase.. J Agric Food Chem 2019 Apr 24;67(16):4505-4512.
Moon KO, Park S, Joo M, Ha KT, Baek NI, Park CS, Cha J. Glycosylation Enhances the Physicochemical Properties of Caffeic Acid Phenethyl Ester.. J Microbiol Biotechnol 2017 Nov 28;27(11):1916-1924.
Li B, Chang S, Jin D, Zhang S, Chen T, Pan X, Fan B, Lv K, He X. Ca(2+) assisted glycosylation of phenolic compounds by phenolic-UDP-glycosyltransferase from Bacillus subtilis PI18.. Int J Biol Macromol 2019 Aug 15;135:373-378.
Nam SH, Kim YM, Walsh MK, Wee YJ, Yang KY, Ko JA, Han S, Thanh Hanh Nguyen T, Kim JY, Kim D. Synthesis and Functional Characterization of Caffeic Acid Glucoside Using Leuconostoc mesenteroides Dextransucrase.. J Agric Food Chem 2017 Apr 5;65(13):2743-2750.
Tambuwala MM, Khan MN, Thompson P, McCarron PA. Albumin nano-encapsulation of caffeic acid phenethyl ester and piceatannol potentiated its ability to modulate HIF and NF-kB pathways and improves therapeutic outcome in experimental colitis.. Drug Deliv Transl Res 2019 Feb;9(1):14-24.
Liu J, Du Y. Method for producing caffeic acid phenyl ester and its analogues. United States Patent (2011) 487:125.
Galland S, Mora N, Abert-Vian M, Rakotomanomana N, Dangles O. Chemical synthesis of hydroxycinnamic acid glucosides and evaluation of their ability to stabilize natural colors via anthocyanin copigmentation.. J Agric Food Chem 2007 Sep 5;55(18):7573-9.
. NTP toxicology and carcinogenesis studies of triethanolamine (Cas No. 102-71-6) in B6C3F1 mice (dermal studies).. Natl Toxicol Program Tech Rep Ser 2004 May;(518):5-163.
Li Y, Zhou X, Yang Z, Zhang L, Yang X, Wei A. Caffeic Acid Reduces Ferroptosis to Dampen Inflammation of Keratinocytes in Psoriasis by Inhibiting EGR1-induced Transcription Activation of CHAC1. Curr Mol Med 2025;25(7):859-870.